Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1995-2-23
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
332
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
529-30
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7830736-Anti-Bacterial Agents,
pubmed-meshheading:7830736-Humans,
pubmed-meshheading:7830736-Infant,
pubmed-meshheading:7830736-Injections, Intramuscular,
pubmed-meshheading:7830736-Poliomyelitis,
pubmed-meshheading:7830736-Poliovirus Vaccine, Oral,
pubmed-meshheading:7830736-Risk Factors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Minimizing the risks associated with the prevention of poliomyelitis.
|
pubmed:publicationType |
Editorial,
Comment
|